...
首页> 外文期刊>Expert review of pharmacoeconomics & outcomes research >Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30
【24h】

Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30

机译:使用EORTC QLQ-BN20和QLQ-C30报道的原发性和转移性脑癌患者的生活质量

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study is to compare the differences in quality of life (QoL) as assessed by the QLQ-BN20 and QLQ-C30 in patients with primary and metastatic brain neoplasms. A systematic literature search was conducted over the OvidSP platform in MEDLINE (1980-2012) and EMBASE (1980-2012). Studies in which the QLQ-BN20 was used as a QoL assessment for patients with malignant brain tumors (either metastatic or primary) were included in the study. Articles were included if they reported scores of at least one subscale of the QLQ-C30 or QLQ-BN20. The weighted means of the QLQ-BN20 and QLQ-C30 subscales were calculated based on sample size for included studies. Weighted analysis of variance was conducted to compare these scores in primary and metastatic brain patients. A p-value of < 0.05 was considered statistically significant. A total of 14 studies (16 arms: three brain metastases and 13 primary brain tumors) were identified and included in the data analysis. Fifteen of the 16 arms included QLQ-C30 scores along with QLQ-BN20 scores. Performance status of patients in both cohorts was similar. Patients with primary brain tumors and brain metastases had the following findings: physical functioning (weighted mean: 79.18 vs 74.93), global QoL (61.88 vs 59.44), role functioning (67.37 vs 75.00) and emotional functioning (70.44 vs 71.86); but none of them were statistically significantly different. Only cognitive functioning from the QLQ-C30 was significantly worse in patients with primary brain tumors (p-value = 0.0199). Despite cognitive function being significantly worse in patients with primary brain tumors, patients with metastatic brain tumors and patients with primary brain tumors have very similar QoL profiles. The study is limited by the large discrepancy in cohort sizes (1260 patients with primary brain cancer vs 183 patients with brain metastases) and the lack of clinical data.
机译:这项研究的目的是比较由QLQ-BN20和QLQ-C30评估的原发性和转移性脑肿瘤患者的生活质量(QoL)差异。通过MEDLINE(1980-2012)和EMBASE(1980-2012)的OvidSP平台进行了系统的文献检索。本研究包括使用QLQ-BN20评估患有恶性脑肿瘤(转移性或原发性)的患者的QoL评估的研究。如果文章的得分至少为QLQ-C30或QLQ-BN20的一个子量表,则将其包括在内。根据纳入研究的样本量计算QLQ-BN20和QLQ-C30分量表的加权平均值。进行方差的加权分析以比较原发性和转移性脑病患者的这些评分。 P值<0.05被认为具有统计学意义。总共鉴定了14项研究(16项研究:3个脑转移瘤和13个原发性脑肿瘤),并将其纳入数据分析。 16组中的15组包括QLQ-C30分数和QLQ-BN20分数。两个队列中患者的表现状态相似。患有原发性脑肿瘤和脑转移的患者具有以下发现:身体功能(加权平均:79.18 vs 74.93),总体QoL(61.88 vs 59.44),角色功能(67.37 vs 75.00)和情绪功能(70.44 vs 71.86);但它们在统计学上均无显着差异。在患有原发性脑肿瘤的患者中,只有QLQ-C30的认知功能明显较差(p值= 0.0199)。尽管原发性脑肿瘤患者的认知功能明显变差,但转移性脑瘤患者和原发性脑肿瘤患者的QoL曲线非常相似。该研究受到队列规模的巨大差异(1260例原发性脑癌患者与183例脑转移性患者)的限制以及缺乏临床数据的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号